{
    "Rank": 346,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT02523417",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "Breast Cancer HepaSphere"
                },
                "Organization": {
                    "OrgFullName": "Fuda Cancer Hospital, Guangzhou",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "HepaSphere Interventional Therapy Using Digital Subtraction Angiography\uff08DSA\uff09for Breast Cancer",
                "OfficialTitle": "HepaSphere Interventional Therapy Using Digital Subtraction Angiography\uff08DSA for Breast Cancer: Clinical Trial"
            },
            "StatusModule": {
                "StatusVerifiedDate": "October 2015",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "May 2015"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "February 2016",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "February 2016",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "August 12, 2015",
                "StudyFirstSubmitQCDate": "August 13, 2015",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "August 14, 2015",
                    "StudyFirstPostDateType": "Estimate"
                },
                "LastUpdateSubmitDate": "February 23, 2016",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "February 25, 2016",
                    "LastUpdatePostDateType": "Estimate"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Sponsor"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Fuda Cancer Hospital, Guangzhou",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "Yes"
            },
            "DescriptionModule": {
                "BriefSummary": "The purpose of this study is to evaluate the safety and efficacy of HepaSphere interventional therapy using digital subtraction angiography\uff08DSA\uff09for breast cancer.",
                "DetailedDescription": "By enrolling patients with breast cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of HepaSphere interventional therapy using digital subtraction angiography\uff08DSA\uff09for breast cancer."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Breast Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Breast Cancer",
                        "HepaSphere"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Interventional",
                "PhaseList": {
                    "Phase": [
                        "Phase 1",
                        "Phase 2"
                    ]
                },
                "DesignInfo": {
                    "DesignAllocation": "Randomized",
                    "DesignInterventionModel": "Parallel Assignment",
                    "DesignPrimaryPurpose": "Treatment",
                    "DesignMaskingInfo": {
                        "DesignMasking": "None (Open Label)"
                    }
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "15",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "HepaSphere",
                            "ArmGroupType": "Experimental",
                            "ArmGroupDescription": "breast cancer patients received HepaSphere interventional therapy using the digital subtraction angiography\uff08DSA\uff09",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Procedure: interventional therapy"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "control",
                            "ArmGroupType": "Placebo Comparator",
                            "ArmGroupDescription": "breast cancer patients received traditional therapy",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Procedure: interventional therapy"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Procedure",
                            "InterventionName": "interventional therapy",
                            "InterventionDescription": "breast cancer patients received HepaSphere interventional therapy using the digital subtraction angiography\uff08DSA\uff09",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "HepaSphere",
                                    "control"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Number of participants with Adverse events",
                            "PrimaryOutcomeTimeFrame": "1 year"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Percentage of lesions interventional therapy that show no sign of recurrence 12 months after",
                            "SecondaryOutcomeTimeFrame": "1 year"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Progress free disease (PFS)",
                            "SecondaryOutcomeTimeFrame": "1 year"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Overall survival (OS)",
                            "SecondaryOutcomeTimeFrame": "3 year"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nAge:18-80\nKarnofsky performance status >60\nDiagnosis of breast cancer based on histology or the current accepted radiological measures.\nClassification tumor,nodes,metastasis-classification(TNM) stage: \u2161,\u2162,\u2163\nWill receive interventional therapy\nLife expectancy: Greater than 3 months\nPatients' routine blood test, liver function and kidney function have no obvious abnormalities\nAbility to understand the study protocol and a willingness to sign a written informed consent document\n\nExclusion Criteria:\n\nPatients with other primary tumor except breast cancer\nHistory of coagulation disorders or anemia",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "18 Years",
                "MaximumAge": "80 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Adult",
                        "Older Adult"
                    ]
                }
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Lizhi Niu, PhD",
                            "OverallOfficialAffiliation": "Fuda Cancer Hospital",
                            "OverallOfficialRole": "Study Chair"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Central laboratory in Fuda cancer hospital",
                            "LocationCity": "Guangzhou",
                            "LocationState": "Guangdong",
                            "LocationZip": "510000",
                            "LocationCountry": "China"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "ReferenceList": {
                    "Reference": [
                        {
                            "ReferencePMID": "23806858",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Niu L, Chen J, Yao F, Zhou L, Zhang C, Wen W, Bi X, Hu Y, Piao X, Jiang F, Zeng J, Liu W, Li J, He L, Mu F, Zuo J, Xu K. Percutaneous cryoablation for stage IV lung cancer: a retrospective analysis. Cryobiology. 2013 Oct;67(2):151-5. doi: 10.1016/j.cryobiol.2013.06.005. Epub 2013 Jun 24."
                        }
                    ]
                },
                "SeeAlsoLinkList": {
                    "SeeAlsoLink": [
                        {
                            "SeeAlsoLinkLabel": "related information",
                            "SeeAlsoLinkURL": "http://www.ncbi.nlm.nih.gov/pubmed/25937772"
                        }
                    ]
                }
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000001943",
                            "ConditionMeshTerm": "Breast Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000001941",
                            "ConditionAncestorTerm": "Breast Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012871",
                            "ConditionAncestorTerm": "Skin Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M4910",
                            "ConditionBrowseLeafName": "Breast Neoplasms",
                            "ConditionBrowseLeafAsFound": "Breast Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M4908",
                            "ConditionBrowseLeafName": "Breast Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M15364",
                            "ConditionBrowseLeafName": "Skin Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC17",
                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}